ClinicalTrials.Veeva

Menu

Cost-effectiveness of FDG-PET

U

University of Sao Paulo

Status

Completed

Conditions

Oncologic Patients

Study type

Observational

Funder types

Other

Identifiers

NCT01438164
USP0460/05

Details and patient eligibility

About

Evaluation of cost-effectiveness of FDG-PET for the public health system in Brazil.

Full description

To provide detailed information about cost and effectiveness of FDG-PET in multiple oncological diseases, such as Lymphoma, lung cancer and esophageal cancer.

Enrollment

500 patients

Sex

All

Ages

13+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Cancer

Exclusion criteria

  • Other malignancy
  • Uncontrolled Diabetes
  • Pregnancy

Trial design

500 participants in 1 patient group

oncologic patients
Description:
initial staging

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems